These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations. Turk DC; O'Connor AB; Dworkin RH; Chaudhry A; Katz NP; Adams EH; Brownstein JS; Comer SD; Dart R; Dasgupta N; Denisco RA; Klein M; Leiderman DB; Lubran R; Rappaport BA; Zacny JP; Ahdieh H; Burke LB; Cowan P; Jacobs P; Malamut R; Markman J; Michna E; Palmer P; Peirce-Sandner S; Potter JS; Raja SN; Rauschkolb C; Roland CL; Webster LR; Weiss RD; Wolf K Pain; 2012 Oct; 153(10):1997-2008. PubMed ID: 22770841 [TBL] [Abstract][Full Text] [Related]
3. Abuse liability measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations. O'Connor AB; Turk DC; Dworkin RH; Katz NP; Colucci R; Haythornthwaite JA; Klein M; O'Brien C; Posner K; Rappaport BA; Reisfield G; Adams EH; Balster RL; Bigelow GE; Burke LB; Comer SD; Cone E; Cowan P; Denisco RA; Farrar JT; Foltin RW; Haddox DJ; Hertz S; Jay GW; Junor R; Kopecky EA; Leiderman DB; McDermott MP; Palmer PP; Raja SN; Rauschkolb C; Rowbotham MC; Sampaio C; Setnik B; Smith SM; Sokolowska M; Stauffer JW; Walsh SL; Zacny JP Pain; 2013 Nov; 154(11):2324-2334. PubMed ID: 24148704 [TBL] [Abstract][Full Text] [Related]
4. Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting. Brown J; Setnik B; Lee K; Wase L; Roland CL; Cleveland JM; Siegel S; Katz N J Opioid Manag; 2011; 7(6):467-83. PubMed ID: 22320029 [TBL] [Abstract][Full Text] [Related]
5. The Contribution of Differential Opioid Responsiveness to Identification of Opioid Risk in Chronic Pain Patients. Bruehl S; Burns JW; Passik SD; Gupta R; Buvanendran A; Chont M; Schuster E; Orlowska D; France CR J Pain; 2015 Jul; 16(7):666-75. PubMed ID: 25892658 [TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
8. Educational intervention for physicians to address the risk of opioid abuse. Pasquale MK; Sheer RL; Mardekian J; Masters ET; Patel NC; Hurwitch AR; Weber JJ; Jorga A; Roland CL J Opioid Manag; 2017; 13(5):303-313. PubMed ID: 29199396 [TBL] [Abstract][Full Text] [Related]
9. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse (Part 2). Kaye AD; Jones MR; Kaye AM; Ripoll JG; Jones DE; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L Pain Physician; 2017 Feb; 20(2S):S111-S133. PubMed ID: 28226334 [TBL] [Abstract][Full Text] [Related]
10. Human drug abuse liability assessment: opioids and analgesics. Bigelow GE Br J Addict; 1991 Dec; 86(12):1615-23. PubMed ID: 1686196 [TBL] [Abstract][Full Text] [Related]
11. Issues in long-term opioid therapy: unmet needs, risks, and solutions. Passik SD Mayo Clin Proc; 2009 Jul; 84(7):593-601. PubMed ID: 19567713 [TBL] [Abstract][Full Text] [Related]
12. Approaches to improve pain relief while minimizing opioid abuse liability. Webster LR; Fine PG J Pain; 2010 Jul; 11(7):602-11. PubMed ID: 20444651 [TBL] [Abstract][Full Text] [Related]
13. Introduction: landscape of opioid dependence. Jan SA J Manag Care Pharm; 2010 Feb; 16(1 Suppl B):S4-8. PubMed ID: 20146548 [TBL] [Abstract][Full Text] [Related]
14. Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations. Turk DC; Dworkin RH; Burke LB; Gershon R; Rothman M; Scott J; Allen RR; Atkinson HJ; Chandler J; Cleeland C; Cowan P; Dimitrova R; Dionne R; Farrar JT; Haythornthwaite JA; Hertz S; Jadad AR; Jensen MP; Kellstein D; Kerns RD; Manning DC; Martin S; Max MB; McDermott MP; McGrath P; Moulin DE; Nurmikko T; Quessy S; Raja S; Rappaport BA; Rauschkolb C; Robinson JP; Royal MA; Simon L; Stauffer JW; Stucki G; Tollett J; von Stein T; Wallace MS; Wernicke J; White RE; Williams AC; Witter J; Wyrwich KW Pain; 2006 Dec; 125(3):208-215. PubMed ID: 17069973 [No Abstract] [Full Text] [Related]
15. Evaluating the abuse potential of opioids and abuse-deterrent -opioid formulations: A review of clinical study methodology. Setnik B; Schoedel KA; Levy-Cooperman N; Shram M; Pixton GC; Roland CL J Opioid Manag; 2017; 13(6):485-523. PubMed ID: 29308594 [TBL] [Abstract][Full Text] [Related]
16. Opioid abuse-deterrent strategies: role of clinicians in acute pain management. Webster LR; Brennan MJ; Kwong LM; Levandowski R; Gudin JA Postgrad Med; 2016 Jan; 128(1):76-84. PubMed ID: 26631936 [TBL] [Abstract][Full Text] [Related]
17. Patient perspective, complexities, and challenges in managed care. Jan SA J Manag Care Pharm; 2010 Feb; 16(1 Suppl B):S22-5. PubMed ID: 20146551 [TBL] [Abstract][Full Text] [Related]
18. Prescription Opioid Abuse in Chronic Pain: An Updated Review of Opioid Abuse Predictors and Strategies to Curb Opioid Abuse: Part 1. Kaye AD; Jones MR; Kaye AM; Ripoll JG; Galan V; Beakley BD; Calixto F; Bolden JL; Urman RD; Manchikanti L Pain Physician; 2017 Feb; 20(2S):S93-S109. PubMed ID: 28226333 [TBL] [Abstract][Full Text] [Related]